IGM Biosciences, Inc. , a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases.
Igm Biosciences stock last closed at $1.43, up 4.38% from the previous day, and has decreased 90.43% in one year. It has underperformed other stocks in the Biotechnology industry by 0.57 percentage points. Igm Biosciences stock is currently +13.49% from its 52-week low of $1.26, and -93.64% from its 52-week high of $22.50.
There are currently 59.46M IGMS shares outstanding. The market capitalization of IGMS is $85.03M. In the past 24 hours, 337,166 IGMS shares were traded.
How to Buy Igm Biosciences Stock
Not sure how to invest in Igm Biosciences stock? Here's how.
Figure out where to buy Igm Biosciences stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Igm Biosciences stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Pick your method of payment and add your information.
Analyze Igm Biosciences stock: The Igm Biosciences ticker symbol is IGMS. Is Igm Biosciences stock a good investment? Should you buy shares of IGMS? How do IGMS's underlying business fundamentals look? Do top analysts think Igm Biosciences is a good buy? Why has IGMS's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if IGMS is a good stock to buy).
Make your IGMS buy order: Decide if you will purchase IGMS shares at the current market price or use a limit order to buy IGMS stock at a particular price.
Track your IGMS investment: Create a watchlist to important updates regarding your position in Igm Biosciences stock.
Step 1: Figure out where to buy Igm Biosciences stock
You need a brokerage account to access the NASDAQ market and buy IGMS shares.
A brokerage account enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Technology to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected your brokerage, you need to fill out some personal info so you can invest in IGMS today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Igm Biosciences stock
Once you have selected the best place to buy Igm Biosciences stock, it's very important to research their stock prior to buying, so you truly wrap your head around the risk and upside.
Igm Biosciences Numbers
IGMS Price
$1.43
1w %
0.7%
1y %
-90.43%
5y %
-96.69%
P/E
-0.4x
P/B
1.08x
P/S
29.79x
PEG
N/A
Revenue
$2.92M
Earnings
-$219.84M
Fore. Rev. Growth
107.51%
Fore. Earn. Growth
N/A
Market Cap
$85.03M
Next Earnings
Mar 5, 2025
Next Dividend
N/A
IGMS Overview
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis quickly.
There are more short-term assets than short-term liabilities on the IGMS balance sheet.
IGMS has cash burn of 172583000. It has sufficient cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the IGMS balance sheet.
Signs that IGMS is not financially healthy:
IGMS has a relatively high debt to equity ratio of 2.86.
IGMS profit margin has gone up by 53.4 percentage points in the past year, but the company is still unprofitable.
Total IGMS debt is higher than 5 years ago, relative to shareholder equity.
IGMS has $218.98M in cash and short term investments. This is not enough to cover its annual cash burn of $172.58M.
Is it a good time to buy Igm Biosciences stock, according to Wall Street analysts?
Out of 8 Equities analysts who track IGMS, the consensus analyst rating on IGMS is a Hold
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Latest IGMS Analyst Forecasts
An analyst from Guggenheim maintains IGMS with a strong buy rating and lowers their IGMS price target from $25.00 to $20.00, on Oct 1, 2024.
Robert Driscoll, a top 15% analyst from Wedbush maintains IGMS with a buy rating and lowers their IGMS price target from $25.00 to $22.00, on Oct 1, 2024.
Eric Joseph, a bottom 3% analyst from JP Morgan downgrades IGMS to a strong sell rating and lowers their IGMS price target from $12.00 to $9.00, on Oct 1, 2024.
Robert Burns, a bottom 1% analyst from HC Wainwright & Co. maintains IGMS with a hold rating and lowers their IGMS price target from $12.00 to $11.00, on Sep 5, 2024.
Last year, IGMS revenue was $2.92M. During the last 2 year, IGMS's revenue has grown by 104.61% per year. This was faster than the Biotechnology industry average of 59.48%.
No, Igm Biosciences doesn't provide an income stream by paying out dividends.
IGMS Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your IGMS buy order
You have two main options:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are generally the easiest way to buy.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a particular dollar amount limit, place a limit order.
Click the Open button and eToro will execute your order.
If you need more help investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Igm Biosciences share?
As of Feb 14, 2025, it costs $1.43 to buy one share of Igm Biosciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.72, you can buy 0.5 shares of IGMS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.